According to The New York Times, The Food and Drug Administration issued an order on January 4, 2012 requiring the makers of implantable transvaginal surgical mesh used to treat urinary incontinence in women to study its risks. According to an FDA update, in letters mailed to Johnson & Johnson , C.R. Bard Inc. and 31 …
After first being turned down by the Food and Drug Administration, makers of the weight-loss drug Qnexa claim they have promising new data to report and have asked the FDA to reconsider it’s approval. Vivus, Inc, of Mountain View, Calif., sought FDA approval last year to market Qnexa for weight loss in adults. But the …
A popular consumer watchdog group, Public Citizen, has not given up on recalling a birth control patch that they believe has no business being on the market. The once popular patch, Ortho Evra, needs to be removed from the market, due to an increased risk of blood clot, the group states. But this is not …